R&D The importance of being disruption ready, with Brandon Pence Brandon Pence, recently appointed President and COO of Fujifilm Biosciences, discusses the cell culture media industry and being disruption ready.
Market Access FH25: Commercialising Health Tech and Deeptech, with Pilar F... In a new episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy expert Pilar Fernández Hermida.
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Patients FH25: On patient access and equity, with Roberta Sarno In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with founder, director, and global health advisor.
Digital FH25: On healthcare innovation with Gary Monk In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with healthcare innovation consultant Gary Monk.
Digital FH25: The art of connection at Frontiers Health with Aline N... Aline Noizet, founder of Digital Health Connector, talks with Deep Dive editor Eloise McLennan about the relationships that make innovation possible.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.